HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Yoshihito Nakatani Selected Research

Prostaglandin-E Synthases

3/2021Gene Deletion of Microsomal Prostaglandin E Synthase-1 Suppresses Chemically Induced Skin Carcinogenesis.
1/2021Coordinated action of microsomal prostaglandin E synthase-1 and prostacyclin synthase on contact hypersensitivity.
11/2015Genetic-deletion of Cyclooxygenase-2 Downstream Prostacyclin Synthase Suppresses Inflammatory Reactions but Facilitates Carcinogenesis, unlike Deletion of Microsomal Prostaglandin E Synthase-1.
9/2015Role of microsomal prostaglandin E synthase-1 (mPGES-1)-derived prostaglandin E2 in colon carcinogenesis.
7/2013Microsomal prostaglandin E synthase-1 is induced in alzheimer's disease and its deletion mitigates alzheimer's disease-like pathology in a mouse model.
12/2009Microsomal prostaglandin E synthase-1 in both cancer cells and hosts contributes to tumour growth, invasion and metastasis.
8/2004Reduced pain hypersensitivity and inflammation in mice lacking microsomal prostaglandin e synthase-1.
12/2003Contribution of membrane-associated prostaglandin E2 synthase to bone resorption.
5/2003Potential role of microsomal prostaglandin E synthase-1 in tumorigenesis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Yoshihito Nakatani Research Topics

Disease

6Carcinogenesis
03/2021 - 05/2003
4Neoplasms (Cancer)
03/2021 - 12/2002
3Inflammation (Inflammations)
01/2017 - 12/2002
2Pain (Aches)
11/2015 - 08/2004
2Colorectal Neoplasms (Colorectal Cancer)
09/2015 - 05/2003
2Alzheimer Disease (Alzheimer's Disease)
07/2013 - 08/2012
1Obesity
01/2021
1Contact Dermatitis (Eczema, Contact)
01/2021
1Edema (Dropsy)
01/2021
1Polyps
11/2015
1Aberrant Crypt Foci
11/2015
1Thrombosis (Thrombus)
01/2014
1Mitochondrial Diseases (Mitochondrial Disease)
10/2010
1Neoplasm Metastasis (Metastasis)
12/2009
1Body Weight (Weight, Body)
10/2007
1Arthritis (Polyarthritis)
08/2004
1Rheumatoid Arthritis
08/2004
1Hypersensitivity (Allergy)
08/2004
1Hypoxia (Hypoxemia)
04/2004
1Bone Resorption
12/2003
1Fever (Fevers)
12/2002

Drug/Important Bio-Agent (IBA)

9Prostaglandin-E SynthasesIBA
03/2021 - 05/2003
6Dinoprostone (PGE2)FDA Link
03/2021 - 12/2002
4ProstaglandinsIBA
03/2021 - 12/2003
3prostacyclin synthetase (prostacyclin synthase)IBA
01/2021 - 11/2015
2EnzymesIBA
03/2021 - 09/2015
2Acetic Acid (Vinegar)FDA LinkGeneric
11/2015 - 08/2004
2Cyclooxygenase 2 (Cyclooxygenase-2)IBA
11/2015 - 09/2015
2Prostaglandins EIBA
09/2015 - 12/2003
2Calcium-Independent Phospholipases A2IBA
01/2014 - 10/2010
2Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA
07/2013 - 08/2012
1anthraceneIBA
03/2021
1DinitrofluorobenzeneIBA
01/2021
1Epoprostenol ReceptorsIBA
01/2021
1LipidsIBA
01/2017
1LipopolysaccharidesIBA
11/2015
1AzoxymethaneIBA
11/2015
1Anticarcinogenic AgentsIBA
11/2015
1Phospholipases (Phospholipase)IBA
10/2010
1Pyridinolcarbamate (P23)IBA
10/2007
1EicosanoidsIBA
04/2005
1CollagenIBA
08/2004
1Transcription Factors (Transcription Factor)IBA
04/2004
1ElementsIBA
04/2004
1Proteins (Proteins, Gene)FDA Link
04/2004
1Antisense OligonucleotidesIBA
12/2003
1CytokinesIBA
12/2003
1AgarIBA
05/2003

Therapy/Procedure

1Chemoprevention
09/2015
1Drug Therapy (Chemotherapy)
09/2015